Académique Documents
Professionnel Documents
Culture Documents
Sutikno Tanuwidjaja Subbagian Kardiologi Bagian Ilmu Penyakit Dalam FK UNDIP/RS Dr. Kariadi Semarang
LUNGS
RIGHT HEART
LEFT HEART
BODY ORGANS
CAPILLARIES
CELLS
Intracellular space - 30 L
Major body fluid compartments with average volumes indicated for a 70-kg human. Total body water is about 60% of body weight.
ECV (14L)
PV (3 L)
Volume distribusi air mencakup volume intraselular (ICV) dan ekstraselular (ECV).
Arterial end
BLOOD CAPILLARY
Venous end
LYMPHATIC CAPILLARY
Diffusion of fluid and dissolved substances between the capillary and interstitial space
Interstitial space
Diffusion of oxygen
The structures of the alveolar-capillary membrane over which reciprocal diffusion of oxygen and carbon dioxide occurs
ALVEOLUS
CAPILLARY
100%
LUNGS
100% 3%
HEART MUSCLE
100%
14%
BRAIN
15%
SKELETAL MUSCLE
BONE
5% 21% ARTERIES
VEINS
GASTROINTESTINAL SYSTEM, SPLEEN
6%
LIVER
22%
KIDNEY
6%
SKIN
8%
OTHER
Progression Mechanism of death Sudden death 40% Worsening CHF 40% Other 20%
Annual mortality
<5%
Asymptomatic
10%
Mild
20 to 30%
Moderate
30 to 80%
Severe
Males Females
60 50 40 30 20
10
0 45-54 55-64 65-74 75-84 85-94
Age (yr)
Hemodynamic
Vasodilators or
Neurohormonal
ACE-I, -blockers
positive inotropes to
relieve ventricular wall stress
1940s
1960s
1970s
1990s - 2000
Vasoconstriction
Na+
LV dilatation
Arrhythmias
Exercise Intolerance
Edema, Congestion
Sudden Death
Pump Failure
Heart
Coronary
LV Dysfunction
Neuroendocrine
Vasoconstriction
Peripheral organ blood flow
Skeletal muscle Blood flow Exercise intolerance
Angiotensin II
Aldosterone release
Edema
Diuresis
Vasodilatation
Prostaglandins
Myocardial dysfunction
AVP Renin All Aldosterone
Endothelins Catecholamines
Apoptosis Hypertrophy
Vasoconstriction
Adaptive
Myocyte slippage
Remodeling
Increased myocardial volume Increased myocardial mass Increased stroke volume (Starling)
Ischemia
Stretch
Humoral RAAS Epinephrine Endothelin Growth factors
Myocyte hypertrophy
Interstitial fibrosis
CARDIAC REMODELING
Cardiac remodeling may be defined as genome expression,
Index Event (myocardial injury) 0.60 LV Ejection Fraction 0.20 Asymptomatic Symptomatic
Low BP
kidney
Baroreflexes
Adrenergic stimulation
RV
LA
RENIN
EXCESS AFTERLOAD
Angiotensin Aldosterone
heart
Increasing preload
AFTERLOAD
CARDIAC OUTPUT
XX X
X X
X XX
X XX XX XX X X XX X XX
(Goldsmith & Dick, 1993)
Remodeling
Death
Cardiomyopathy
Valvular disease
Pump failure
(Abraham, 2000)
Symptoms NYHA - IV
Symptoms
Aims of treatment
Prevention
a) Prevention and/or controlling of diseases leading to cardiac dysfunction and heart failure b) Prevention of progression to heart failure once cardiac dysfunction is established
Morbidity
Maintenance or improvement in quality of life
Mortality
Increased duration of life
Guidelines for the diagnosis and treatment of chronic heart failure European Heart Journal (2001) 22, 1527-1560
DIURETICS
Thiazides
Cortex
Inhibit active exchange of Cl-Na in the cortical diluting segment of the ascending loop of Henle
K-sparing
Inhibit reabsorption of Na in the distal convoluted and collecting tubule
Medulla
Loop of Henle
Loop diuretics
Inhibit exchange of Cl-Na-K in the thick segment of the ascending loop of Henle
Collecting tubule
Opie (2001)
DOSE
Vasodilator only
Diuretic only
Low-output symptoms
Left ventricular filling pressure
INITIAL EVENT
Myocardial Insult and/or Excessive Load
CLINICAL SYNDROME
PATHOPHYSIOLOGY
CHF
Increased Afterload
TRIALS
The pathophysiology of heart failure progressing with time from the initial event. (Lejemtel et al, 2001)
CHF
Positive inotropic effect
3 Na+ 2K+
Digoxin
Na+
NE
+
SA
AV
Na+ rises
Ca2+
Toxic arrhythmias
Digitalis has both neural and myocardial cellular effects. Opie (2001)
Bisoprolol pooled (2 trials) Bucindolol pooled (4 trials) Carvedilol pooled (5 trials) Metoprolol pooled (9 trials) 5 small trials Overall (25 trials)
0.1
0.2
0.5
10
Pooled odds ratios (and 95% confidence intervals) describing the effect of blockers on mortality in patients with heart failure (fixed effects model)
(Cleland et al, 1999)
Vasoconstriction
Increased heart rate and contractility Volume overloaded
Increased MVO2
Hydrostatic forces at either end of the pulmonary capillary favor a driving pressure through the capillary bed of approximately 4 mm Hg. The normal mean forces acting at the pulmonary capillary are as follows : AVERAGE FORCES TENDING TO PUSH FLUID OUT OF THE PULMONARY VASCULAR SPACE
Mean pulmonary capillary hydrostatic pressure Subatmospheric pulmonary interstitial hydrostatic pressure (drawing fluid into the lung) Interstitial oncotic pressure Net Forces Directing Fluid Outward 8.0 mm Hg -10.0 mm Hg +12.0 mm Hg 30.0 mm Hg
Laterstitial space
Alveolus
AVERAGE FORCES TENDING TO PUSH FLUID INTO THE PULMONARY VASCULAR SPACE Plasma oncotic pressure Net Forces Dircted Inward Net forces : Outward Inward Venule AVERAGE FORCES DIRECTING FLUID INTO THE PULMONARY TISSUE SPACE 28.0 mm Hg 28.0 mm Hg 30.0 mm Hg -28.0 mm Hg
2.0 mm Hg
Pulmonary capillary fluid dynamics (Adapted from Wilson RF: Cardiovascular physiology. In Critical care manual, ed 2, Philadelphia, 1992, Davis)
+7
-8
-8 -5000 -8 -4 (0)
-8
-5000
Lymphatic pump
Hydrostatic and osmotic forces at the capillary (left) and alveolar membrane (right) of the lungs. Also shown is a lymphatic (center) that pumps fluid from the pulmonary interstitial spaces. (Modified from Guyton, Taylor, and Granger : Dynamics of the Body Fluids. Philadelphia, W. B. Saunders Company, 1975)
Pathophysiology of CHF
Injury to myocytes and EC matrix Neurohumoral activation Increased cytokines Immune and inflammatory changes altered fibrinolysis
Ventricular remodelling
VEIN
Venules
ARTERY
HEART RATE
PRELOAD
CARDIAC OUTPUT
CONTRACTILITY
MUSCULAR SYNCHRONY
mmHg 120
LV
Aorta LV Pressure LA
80
40 0 ml 120
80
40 0
sv LV Volume RV
R
P Q S Relaxation Passive stiffness Elastic recoil Atrial reserve Factors influencing LV diastole M-mode achocardiography T P ECG
AO
cm/s 80 40 0
MI
Dopplerecho
Cardiac Cycle
Maximal activity
Ventricular performance
2 C Normal-exercise 1
Walking Rest
B D A
Stretching of myocardium
Diagram showing the interrelationship of influences on ventricular end-diastolic Volume (EDV) through stretching of the myocardium and the contractile stase Of the myocardium.
A L
COLD
NO
Low perfusion at rest? YES
A
Cold & Dry L
B
Cold & Wet C
Evidence for low perfusion Narrow pulse pressure8 Cool extremities* May be sleepy, obtunded Suspect from ACEI hypotension And low serum Sodium One cause of worsening renal fn
* Most helpful
+ Inotropic
Decreased fatigue Increased cardiac output
Normal
Pathophysiology of CHF
Injury to myocytes and EC matrix Neurohumoral activation Increased cytokines Immune and inflammatory changes altered fibrinolysis
Ventricular remodelling
HIPOTESA STARLING
Arteriole
AVERAGE FORCES TENDING TO PUSH FLUID OUT OF THE SYSTEMIC VASCULAR SPACE
Interstitial space Mean capillary hydrostatic pressure Subatmospheric interstitial hydrostatic pressure (acting as a vacuum drawing fluid into the interstitium) Interstitial oncotic pressure Systemic cell Net Forces Directing Fluid Outward -6.0 mm Hg +5.3 mm Hg 28.3 mm Hg 17.0 mm Hg
Capillary AVERAGE FORCES TENDING TO PUSH FLUID INTO THE SYSTEMIC VASCULAR SPACE
Plasma oncotic pressure Net Forces Dircted Inward Net forces : Outward Inward 28.0 mm Hg 28.0 mm Hg 28.3 mm Hg -28.0 mm Hg
Venule
0.3 mm Hg
Systemic capillary fluid dynamics (Adapted from Wilson RF: Cardiovascular physiology. In Critical care manual, ed 2, Philadelphia, 1992, Davis)
Preload
Neurohormonal activation
Inotropy
Baroreflex response
Natriuretic peptides Prostaglandins Bradykinin Response to stress Fluid & salt retention
Ca2-
The pathophysiology of heart failure involves the interaction of intrinsic cardiac function wit neurohormonal activation, peripheral vasoconstriction and volume expansion. Neurohormonal activation may increase vasoconstriction and lead to a vicious cycle of worsening cardiac function. Natriuretic peptides and other hormones with vasodilating properties may have potentially beneficial effects on vasoconstriction and volume expansion. This complex model is influenced by numerous factors, including age of patient, drugs, presence of coronary artery disease and the constant feedback of the various regulatory systems. Demonstrated effect; Possible effect; + Positive feedback; - Negative feedback; Decrease; Increase; Ca2+ Intracellular calcium concentrations